Skip to content

BioLife Solutions, Inc.

BLFS

CIK 0000834365

← back to feed
Revenue (TTM)
$6.69M
−30.8% YoY Q1 Apr 2026
Net Income (TTM)
−$14.48M
+77.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.30
+77.3% YoY Q1 Apr 2026
Gross Margin
621.1%
Q1 Apr 2026
Operating Margin
-257.1%
Q1 Apr 2026
Net Margin
-216.4%
Q1 Apr 2026
Free Cash Flow (TTM)
−$11.04M
Q1 Apr 2026
Cash
$22.82M
Q1 Apr 2026
Total Debt
$2.5M
Q1 Apr 2026
Shares Outstanding
48.86M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings